Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
Sep 17, 2017 22:00 pm UTC| Business
MELBOURNE, Australia, Sept. 18, 2017 -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been appointed to the Board of Telix...
PHOTO RELEASE--Huntington Ingalls Industries Christens Amphibious Assault Ship Tripoli (LHA 7)
Sep 16, 2017 18:46 pm UTC| Business
PASCAGOULA, Miss., Sept. 16, 2017 -- Huntington Ingalls Industries’ (NYSE:HII) Ingalls Shipbuilding division christened the amphibious assault ship Tripoli (LHA 7) today with approximately 2,000 guests in attendance. ...
Youth INC and RBC Host Lower Manhattan Community Event and Raise $2MM+ for NYC Youth
Sep 16, 2017 16:57 pm UTC| Business
NEW YORK, Sept. 16, 2017 -- New York City Deputy Mayor, Rich Buery, and New York Giants and University of Michigan legend, Amani Toomer, presided over the awards for over 3,000 New Yorkers who participated in the third...
Bassett Furniture Announces Opening of New Store in Pittsburgh, PA
Sep 16, 2017 16:00 pm UTC| Business
BASSETT, Va., Sept. 16, 2017 -- Bassett Furniture Industries, Inc. (NASDAQ:BSET), a leading manufacturer and marketer of high quality home furnishings, today announced the opening of its new Bassett Home Furnishings...
Sep 16, 2017 12:00 pm UTC| Business
NEW YORK, Sept. 16, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Blue Apron Holdings, Inc. (“Blue Apron” or the “Company”) (NYSE:APRN) and certain of its officers. The class...
Sep 16, 2017 06:18 am UTC| Business
Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis - Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European...
Sep 16, 2017 06:18 am UTC| Business
Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis - Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European...